Sandoz signs 10-year agreement with partner Delpharm, a global pharmaceutical developer and contract manufacturerAgreement will secure a reliable ...
In a report released on March 17, Nicolas Pauillac from Kepler Capital maintained a Buy rating on Sandoz Group Ltd (SDZXF – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback